D63-26041-84411 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-30
Dose 1 — Pfizer-BioNTech
2022-09-10
Dose 2 — Pfizer-BioNTech
2022-09-16
Registered in v-safe
2022-09-16
Survey response — days 1–6 daily, dose 2, dependent
MedDRA: Rash — Feeling: Good · Fever · Rash, not including the immediate area around the injection site · Be unable to work or attend school

Free text: We think his rash is HFM disease

MedDRA releases: 2024-11 · check-in free text available
2022-09-17
Health check-in — day 7, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-09-24
Health check-in — day 14, dose 2, dependent
Feeling: Good

Adult check-in
2022-10-03
Health check-in — day 21, dose 2, dependent
Feeling: Good

Adult check-in
2022-10-08
Health check-in — day 28, dose 2, dependent
Feeling: Good

Adult check-in
2022-10-15
Health check-in — day 35, dose 2, dependent
Feeling: Good

Adult check-in
2022-10-24
Health check-in — day 42, dose 2, dependent
Feeling: Good

Adult check-in
2022-12-10
Health check-in — 3 months, dose 2, dependent
Feeling: Good

Adult check-in
2023-03-11
Health check-in — 6 months, dose 2, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-30	Pfizer-BioNTech	No
2	2022-09-10	Pfizer-BioNTech	No

Free text

Release 12 — days 1–6 daily, dose 2, dependent

2022-09-16

Systemic reaction (other): We think his rash is HFM disease

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Rash	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release